Jaguar Health Statistics

Total Valuation

Jaguar Health has a market cap or net worth of $48.92 million. The enterprise value is $79.54 million.

Market Cap	48.92M
Enterprise Value	79.54M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Jaguar Health has 276.22 million shares outstanding. The number of shares has increased by 1,658.91% in one year.

Shares Outstanding	276.22M
Shares Change (YoY)	+1,658.91%
Shares Change (QoQ)	+11.23%
Owned by Insiders (%)	1.78%
Owned by Institutions (%)	0.45%
Float	274.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.01
Forward PS	3.47
PB Ratio	9.86
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 7.48.

Current Ratio	2.00
Quick Ratio	0.62
Debt / Equity	7.48
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.47

Financial Efficiency

Return on equity (ROE) is -855.60% and return on invested capital (ROIC) is -81.54%.

Return on Equity (ROE)	-855.60%
Return on Assets (ROA)	-80.50%
Return on Capital (ROIC)	-81.54%
Revenue Per Employee	$199,204
Profits Per Employee	-$842,857
Employee Count	49
Asset Turnover	0.19
Inventory Turnover	0.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.92% in the last 52 weeks. The beta is 1.38, so Jaguar Health's price volatility has been higher than the market average.

Beta (1Y)	1.38
52-Week Price Change	-70.92%
50-Day Moving Average	0.09
200-Day Moving Average	0.27
Relative Strength Index (RSI)	70.84
Average Volume (30 Days)	58,314,854

Short Selling Information

The latest short interest is 19.71 million, so 7.13% of the outstanding shares have been sold short.

Short Interest	19.71M
Short Previous Month	7.44M
Short % of Shares Out	7.13%
Short % of Float	7.18%
Short Ratio (days to cover)	0.26

Income Statement

In the last 12 months, Jaguar Health had revenue of $9.76 million and -$41.30 million in losses. Loss per share was -$1.79.

Revenue	9.76M
Gross Profit	7.72M
Operating Income	-34.29M
Pretax Income	-41.30M
Net Income	-41.30M
EBITDA	-32.53M
EBIT	-34.92M
Loss Per Share	-$1.79

Full Income Statement

Balance Sheet

The company has $6.47 million in cash and $37.09 million in debt, giving a net cash position of -$30.63 million or -$0.11 per share.

Cash & Cash Equivalents	6.47M
Total Debt	37.09M
Net Cash	-30.63M
Net Cash Per Share	-$0.11
Equity / Book Value	4.96M
Book Value Per Share	0.02
Working Capital	13.98M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-33.24M
Capital Expenditures	n/a
Free Cash Flow	-33.24M
FCF Per Share	-$1.44

Full Cash Flow Statement

Margins

Gross margin is 79.13%, with operating and profit margins of -351.31% and -423.11%.

Gross Margin	79.13%
Operating Margin	-351.31%
Pretax Margin	-423.11%
Profit Margin	-423.11%
EBITDA Margin	-333.27%
EBIT Margin	-357.73%
FCF Margin	-340.56%

Dividends & Yields

Jaguar Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,658.91%
Shareholder Yield	-1,658.91%
Earnings Yield	-84.43%
FCF Yield	-67.95%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 23, 2023. It was a reverse split with a ratio of 1:75.

Last Split Date	Jan 23, 2023
Split Type	Reverse
Split Ratio	1:75

Scores

Jaguar Health has an Altman Z-Score of -9.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.61
Piotroski F-Score	2